Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,522 | -70,358 | -31,644 | -81,355 | -56,733 |
| Depreciation Amortization | 3,667 | 2,418 | 868 | 1,002 | 486 |
| Accounts payable and accrued liabilities | -1,280 | 685 | 1,045 | 2,198 | -266 |
| Other Working Capital | 1,734 | 706 | -3,662 | 2,045 | 3,931 |
| Other Operating Activity | 20,719 | 11,273 | 5,131 | 8,229 | 8,043 |
| Operating Cash Flow | $-89,682 | $-55,276 | $-28,262 | $-67,881 | $-44,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,481 | -9,235 | -6,073 | -17,502 | -10,794 |
| Purchase Of Investment | -111,108 | -48,000 | -12,989 | -207,986 | -163,747 |
| Sale Of Investment | 135,810 | 117,566 | 58,673 | 283,777 | 211,602 |
| Investing Cash Flow | $13,221 | $60,331 | $39,611 | $58,289 | $37,061 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,403 | 929 | 365 | 216,512 | 364 |
| Other Financing Activity | -1,418 | -1,015 | -418 | -1,731 | -1,493 |
| Financing Cash Flow | $985 | $-86 | $-53 | $214,781 | $-1,129 |
| Beginning Cash Position | 241,080 | 241,080 | 241,080 | 35,891 | 35,891 |
| End Cash Position | 165,604 | 246,049 | 252,376 | 241,080 | 27,284 |
| Net Cash Flow | $-75,476 | $4,969 | $11,296 | $205,189 | $-8,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,682 | -55,276 | -28,262 | -67,881 | -44,539 |
| Capital Expenditure | -11,481 | -9,235 | -6,073 | -17,502 | -10,794 |
| Free Cash Flow | -101,163 | -64,511 | -34,335 | -85,383 | -55,333 |